Create account

Coverage dated September 23, 2026

U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast

Headline from Fortune

"The growth is mainly due to Novo’s sales and production in the U.S. market at the beginning of this year."

Fortune's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

2 articles, oldest first.

  1. Bloomberg

    Danish Central Bank Doubles Growth Forecast on Novo’s US Boom (opens Bloomberg)

    Published

    Bloomberg's feed description

    Denmark’s central bank more than doubled its growth forecast for this year as surging US sales and production at Novo Nordisk A/S fuel strong exports in the Nordic country’s pharmaceutical industry.

  2. Fortune

    U.S. demand for Novo Nordisk’s weight loss drugs is so huge that the Danish central bank just doubled the nation’s entire growth forecast (opens Fortune)

    Published

    Fortune's feed description

    "The growth is mainly due to Novo’s sales and production in the U.S. market at the beginning of this year."